Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PRMT1 | Q99873 | 15/20 | 0.69 |
| ▸ | PRMT3 | O60678 | 1/20 | 0.45 |
| ▸ | EHMT2 | Q96KQ7 | 1/20 | 0.45 |
| ▸ | PRMT6 | Q96LA8 | 1/20 | 0.45 |
| ▸ | PRMT8 | Q9NR22 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8425061 | 0.91 | PRMT1 (0.71) | PRMT1PRMT3EHMT2PRMT6PRMT8 | |
| SCHEMBL8235643 | 0.87 | PRMT1 (0.88) | PRMT1PRMT3EHMT2PRMT6PRMT8 | |
| SCHEMBL8235621 | 0.87 | PRMT1 (0.88) | PRMT1PRMT3EHMT2PRMT6PRMT8 | |
| SCHEMBL12735725 | 0.83 | PRMT1 (0.79) | PRMT1 | |
| SCHEMBL12711215 | 0.82 | PRMT1 (0.79) | PRMT1PRMT3EHMT2PRMT6PRMT8 | |
| SCHEMBL20184751 | 0.82 | PRMT1 (1.00) | PRMT1PRMT3EHMT2PRMT6PRMT8 | |
| SCHEMBL8238368 | 0.81 | PRMT1 (0.77) | PRMT1PRMT3EHMT2PRMT6PRMT8 | |
| SCHEMBL8815310 | 0.79 | PRMT1 (0.88) | PRMT1 | |
| SCHEMBL17084488 | 0.79 | PRMT1 (0.88) | PRMT1 | |
| SCHEMBL7979972 | 0.79 | PRMT1 (0.88) | PRMT1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110086877-A1 | Small Molecule Inhibitors of Botulinum Neurotoxins | BAVARI SINA | 2011-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110086877-A1 | Small Molecule Inhibitors of Botulinum Neurotoxins | ACHE, MMP2, TIMP3 | PRMT1 2768/4885PRMT3 2069/4885EHMT2 4668/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.